MLEC
Moolec Science SA
NASDAQ · Healthcare · Biotechnology · LU
$6.10
−2.09%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$6.33
From 52W high−67.20%
Volume3687.00
Market cap$12.69M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataSep 18, 2026
Open
$6.33
From 52W high
−67.20%
Volume
3687.00
Market cap
$12.69M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.5x
P/E (TTM)
—
RSI (14)
39.7
MomentumView details →
1D Return
−2.09%
YTD Return
+60.21%
SummaryUpdated Jun 1, 2025
Moolec Science SA (NASDAQ:MLEC) is a Luxembourg-based biotechnology company founded in 2008 that specializes in producing animal proteins in plants through a technology called Molecular Farming. The company went public in March 2021 and operates across the United States, Europe, and South America. Moolec represents a disruptive approach in the alternative protein landscape, leveraging the natural efficiency of crops like soybeans and peas to produce traditionally animal-derived proteins through genetic engineering techniques.
Similar companies
Latest newsMore news →
No recent news for MLEC.